Genentech and Ensemble in collaboration for macrolytic drug candidates
09:51 EDT 30 May 2012 | Current Partnering
Ensemble Therapeutics announced the initiation of a drug discovery collaboration with Genentech, a member of Roche, to discover macrocyclic drug candidates against targets specified by Genentech. The collaboration will deploy Ensemble’s proprietary drug discovery platform, including its Ensemblin collection of over 5 million macrocycles, to discover novel drug candidates against Genentech’s drug targets. Genentech will [...
Original Article: Genentech and Ensemble in collaboration for macrolytic drug candidates
More From BioPortfolio on "Genentech and Ensemble in collaboration for macrolytic drug candidates"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
